谷歌浏览器插件
订阅小程序
在清言上使用

A Multicenter Randomized Open-Label Phase 2 Study Investigating Optimal Antiemetic Therapy for Patients with Advanced/recurrent Gastric Cancer Treated with Trastuzumab Deruxtecan: the EN-hance Study

International Journal of Clinical Oncology(2025)

引用 0|浏览3
关键词
Phase 2 study,Antiemetic therapy,Gastric cancer,Trastuzumab deruxtecan
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要